Our plan network includes doctors, specialists, hospitals and other health care providers
Aroda VR, Gonzlez-Galvez G, Grn R et al (2019) Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
Thirteen studies were performed in the United States [11, 15,16,17, 20, 22, 35, 36, 40, 43,44,45,46], 9 in Denmark [12, 13, 18, 19, 21, 24, 28, 31, 34], 4 both in China [23, 33, 48, 49] and Slovenia [25,26,27, 39], 3 in Canada [14, 29, 47], 2 in Italy [37, 38], 1 in United Kingdom [30], Sweden [32], Australia [41], and Netherlands [42], respectively
The Big Question: Do GLP-1 Patches Work
Simplified treatment schedule with weekly injections